
About Eiken Chemical
Eiken Chemical is a publicly listed company based in Tokyo (Japan) founded in 1939. Diagnostic kits and reagents are supplied for life sciences research. The company has 702 employees. Its chief executive, as recorded, is Tsugunori Notomi. Its website eiken.co.jp draws about 50 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified.
Company details
Eiken Chemical was established in 1939 and is headquartered in Tokyo, Japan. Operations focus on the life sciences sector, where diagnostic kits and reagents are developed for identifying infectious microorganisms, conducting drug sensitivity tests, and performing fecal blood tests for colon cancer detection. Urine analysis solutions for kidney and diabetes screening are also provided, alongside foodborne disease-detection kits, rapid point-of-care testing, and immunoassay reagents used in ELISA and chromatography applications.
- Headquarters Tokyo, Japan
- Employees 702
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phoneβ’β’β’β’ β’β’β’β’
- Website eiken.co.jp
- Legal Name Eiken Chemical Co., Ltd.
- Annual Revenue$262.7 M (USD)3.35as on Mar 31, 2026
- Net Profit$23.26 M (USD)66.43as on Mar 31, 2026
- EBITDA$34.23 M (USD)-1.75as on Mar 31, 2026
- Employee Count702
People of Eiken Chemical
1 people are tracked at Eiken Chemical (1 in leadership); the tracked headcount is 702.
| Name | Role | Group |
|---|---|---|
Tsugunori Notomi | CEO & President | Leadership |
Complete people profiles for Eiken Chemical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Eiken Chemical
Eiken Chemical is a publicly listed company on the TSE with ticker symbol 4549 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date29 Jan 1990
- Listed onTSE: 4549
- Listed entityEiken Chemical Co., Ltd.
- Exchange sectorHealth technology
- ISINJP3160700005
- Share price2,457.00 JPY (+0.82% on the day) · 2026-10-14
- Market capitalisation80,343,505,066.00 JPY
- Price to earnings22.8
- EPS (diluted, trailing year)107.71 JPY
- Dividend yield2.38%
- Volume (last session)95,700
Financials of Eiken Chemical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 41.90B JPY | 3.71B JPY | 5.46B JPY |
| 2024 | 40.54B JPY | 2.23B JPY | 5.55B JPY |
| 2023 | 40.05B JPY | 2.63B JPY | 5.71B JPY |
| 2022 | 43.27B JPY | 5.74B JPY | 9.58B JPY |
| 2021 | 43.00B JPY | 6.22B JPY | 10.45B JPY |
Detailed financial statements for Eiken Chemical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Eiken Chemical
The website of Eiken Chemical (eiken.co.jp) receives about 49.8K visits a month and ranks #568,945 among all websites worldwide, #592 in Biotechnology and Pharmaceuticals.
- Monthly visits49.8K
▼ 7% vs previous month
- Unique visitors31.2K
per month
- Global rank#568,945
among all websites
- Category rank#592
Health · Biotechnology and Pharmaceuticals
- Bounce rate53%
- Pages per visit2.5
- Average visit58 sec
- DevicesDesktop 51% Β· Mobile 49%
Websites whose visitors overlap most with Eiken Chemical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nissui-pharm.co.jp | nissui-pharm.co.jp | 100% | β | ||
eisai.co.jp | eisai.co.jp | 90% | #356,397 | β | |
| cosmobio.co.jp | 90% | 130.8K | View details | ||
cscjp.co.jp | cscjp.co.jp | 90% | #2,494,959 | β | |
nissinrika.co.jp | nissinrika.co.jp | 90% | #10,134,124 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Eiken Chemical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eiken Chemical
Complete news archive for Eiken Chemical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eiken Chemical
Eiken Chemical was founded in 1939.
Eiken Chemical is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Tsugunori Notomi is the CEO of Eiken Chemical, as recorded in our data.
Eiken Chemical has 702 employees.
Annual revenue of Eiken Chemical is $262.7M as on Mar 31, 2026.
Eiken Chemical was established in 1939 and is headquartered in Tokyo, Japan. Operations focus on the life sciences sector, where diagnostic kits and reagents are developed for identifying infectious microorganisms, conducting drug sensitivity tests, and performing fecal blood tests for colon cancer detection. Urine analysis solutions for kidney and diabetes screening are also provided, alongside foodborne disease-detection kits, rapid point-of-care testing, and immunoassay reagents used in ELISA and chromatography applications.
Yes, Eiken Chemical is publicly traded on TSE under the ticker symbol 4549.
